Home / Topics / molecular targeted therapies

molecular targeted therapies Podcasts

1 episode about molecular targeted therapies

Incyte Corporation Announced Q1 2026 Earnings on April 28, 2026, Reporting "Total revenue in the first quarter of '26 was $1.27 billion". artwork

Incyte Corporation Announced Q1 2026 Earnings on April 28, 2026, Reporting "Total revenue in the first quarter of '26 was $1.27 billion".
Incyte Corporation (INCY)
• 17:50 •Ep 102 •The Earnings Debate •▶ Play on Apple